Open AccessChinese multidisciplinary expert consensus: Guidelines on percutaneous transthoracic needle biopsy
Author(s) -
Guo Zhi,
Shi Hong,
Li Wentao,
Lin Dongmei,
Wang Changli,
Liu Chen,
Yuan Min,
Wu Xia,
Xiong Bin,
He Xinhong,
Duan Feng,
Han Jianjun,
Yang Xueling,
Yu Haipeng,
Si Tongguo,
Xu Linfeng,
Xing Wenge,
Jinhua Huang,
Wang Yingjuan,
Xie Hui,
Cui Li,
Gao Wei,
He Dongfeng,
Liu Changfu,
Liu Zhou,
Ma Chunhua,
Pan Jie,
Shao Haibo,
Tu Qiang,
Yong Li,
Xu Yan,
Weihao Zhang,
Qiang Zou,
Wang Sen
Publication year - 2018
Publication title -
thoracic cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 28
eISSN - 1759-7714
pISSN - 1759-7706
DOI - 10.1111/1759-7714.12849
Subject(s) - medicine , percutaneous , biopsy , radiology , pulmonologist , interventional radiology , perioperative , intensive care medicine , general surgery
Biopsy has been used to diagnose thoracic diseases for more than a century. Percutaneous needle biopsy plays a crucial role in the diagnosis, staging, and treatment planning for tumors in the lungs, thoracic wall, hilum, and mediastinum. With the continuous improvement in imaging techniques, the range of clinical applications for percutaneous needle biopsy is also expanding. It has become important to improve Chinese professionals’ and technicians’ understanding of percutaneous transthoracic needle biopsy (PTNB) in order to standardize operating procedures and to strengthen perioperative management. However, there is currently no Chinese expert consensus that provides systematic standardization and guidance for PTNB in clinical practice. The Committee of Chinese Society of Interventional Oncology (CSIO) of the Chinese Anti‐Cancer Association (CACA) initiated a Chinese multidisciplinary expert consensus on PTNB. The consensus includes image‐guided methods, indications, contraindications, multidisciplinary team recommendations, biopsy procedures, daytime/outpatient biopsy, complications, pathological examination, and management of negative results.